The Egyptian Drug Authority (EDA) has signed a cooperation protocol with Upjohn, one of Pfizer’s divisions, and healthcare technology company Iqvia Egypt and Saudi Arabia to automate the drug distribution process in the domestic market, especially drugs that require tight control.
Deputy Chairman of the EDA Ayman El-Khatib said that the cooperation protocol is consistent with the role the private sector plays in Egypt’s development process. El-Khatib said that the protocol is also consistent with the EDA’s plan for digital transformation and the automation of its services.
Meanwhile, chairman of Upjohn Egypt Mohamed Swilam asserted the importance of providing sustainable solutions for all healthcare partners that can improve patients’ lives, add value to the healthcare systems and reinforce the healthcare infrastructure in Egypt.
He added that the cooperation protocol aims to support the EDA in establishing a robust automated system for drug distribution and boost public-private partnership and cooperation with Egypt’s government, particularly in digital transformation and healthcare automation.
Director-General of Iqvia Egypt and Saudi Arabia Mohamed Mostafa said that the company is eager to support the Egyptian government’s efforts in digital transformation, adding that Iqvia is committed to participating in the EDA’s operations and plans including developing android and IOS apps for mobile phones.
He added that Iqvia’s experience in healthcare technology qualifies it to implement all digital transformation procedures for all partners in Egypt’s healthcare sector.